Use of Pressure Muscle Index to Avoid Over-assistance During Pressure Support Ventilation

December 26, 2021 updated by: Jian-Xin Zhou, Capital Medical University
Pressure support ventilation (PSV) is the most commonly used mode in mechanical ventilated patients. Studies have shown that over-assistance was prevalent in patients undergoing PSV. Up to now, no reliable method has been recommended to select an "optimal" inspiratory support level. Pressure muscle index (PMI) was introduced recently to evaluate the degree of spontaneous breathing effort. We hypothesize that PMI might be used as an indicator for over-assistance during PSV. In this randomized crossover study, inspiratory support is set at three levels according to negative, positive and zero PMI. Inspiratory effort, work of breathing, and respiratory mechanics are compared among the three inspiratory pressure support levels.

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100070
        • Recruiting
        • Beijing Tiantan Hospital
        • Contact:
          • Yan-Lin Yang, MD
      • Beijing, Beijing, China, 100029
        • Recruiting
        • China-Japan Friendship Hospital
        • Contact:
          • De-Jing Song, BS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Mechanical ventilated patients within 48 hours after the transition from a controlled mode to PSV

Exclusion Criteria:

  • History of neuromuscular disease
  • History of diaphragm dysfunction and surgery
  • History of esophageal, gastric or lung surgery
  • Decreased level of consciousness
  • Central respiratory drive dysfunction
  • Considered withholding of life support

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Inspiratory support level with PMI equal to -2
PMI represents the difference between plateau airway pressure and peak airway pressure (plateau - peak) during an end-inspiratory airway occlusion.
Inspiratory support is the pressure delivered by the ventilator during pressure support ventilation.
Experimental: Inspiratory support level with PMI equal to 0
PMI represents the difference between plateau airway pressure and peak airway pressure (plateau - peak) during an end-inspiratory airway occlusion.
Inspiratory support is the pressure delivered by the ventilator during pressure support ventilation.
Experimental: Inspiratory support level with PMI equal to +2
PMI represents the difference between plateau airway pressure and peak airway pressure (plateau - peak) during an end-inspiratory airway occlusion.
Inspiratory support is the pressure delivered by the ventilator during pressure support ventilation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inspiratory effort
Time Frame: 30 minutes
Inspiratory effort is measured as pressure generated by inspiratory muscles using esophageal pressure monitoring.
30 minutes
Work of breathing
Time Frame: 30 minutes
Work of breathing is measured by the Campbell diagram and pressure-time-product using esophageal pressure monitoring.
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory system compliance (ml/cmH2O)
Time Frame: 30 minutes
Respiratory system compliance is calculated as the ratio between tidal volume and driving pressure.
30 minutes
Partial pressure of oxygen in arterial blood (mmHg)
Time Frame: Partial pressure of oxygen in arterial blood
Partial pressure of oxygen in arterial blood is obtained by blood gas analysis.
Partial pressure of oxygen in arterial blood
Partial pressure of carbon dioxide in arterial blood (mmHg)
Time Frame: 30 minutes
Partial pressure of carbon dioxide in arterial blood is obtained by blood gas analysis.
30 minutes
Respiratory rate (breaths/min)
Time Frame: 30 minutes
Respiratory rate calculation includes ineffective trigger.
30 minutes
Tidal volume (ml)
Time Frame: 30 minutes
Tidal volume is obtained by intergation of flow-time tracing.
30 minutes
Rapid shallow breathing index
Time Frame: 30 minutes
Rapid shallow breathing index is calculated as the ratio between respiratory rate and tidal volume.
30 minutes
The use of accessory respiratory muscle
Time Frame: 30 minutes
The use of accessory respiratory muscle is observed at the bedside.
30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Anticipated)

January 1, 2022

Study Completion (Anticipated)

February 1, 2022

Study Registration Dates

First Submitted

August 17, 2021

First Submitted That Met QC Criteria

August 23, 2021

First Posted (Actual)

August 30, 2021

Study Record Updates

Last Update Posted (Actual)

January 11, 2022

Last Update Submitted That Met QC Criteria

December 26, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mechanical Ventilation

Clinical Trials on Inspiratory support level

Subscribe